lung cancer

Web Application Improves Survival and Follow-up for Patients With Lung Cancer

06/10/2016

JCP Editors

Using a web-based application to guide follow-up for patients with advanced lung cancer after they have received initial therapy may improve survival, according to a study presented at the 2016 American Society of...

Using...

06/10/2016

Journal of Clinical Pathways

Research in Review

Algorithm Can Help Reduce Delays in Lung Cancer Evaluation

05/19/2016

JCP Editors

An algorithm designed to identify patients with a risk of cancer in need of follow-up may help to reduce delays in the diagnostic evaluation of abnormal chest imaging results, according to a recent...

An...

05/19/2016

Journal of Clinical Pathways

Research in Review

Surgery Offers Survival Benefit to Older Patients With Lung Cancer

05/12/2016

JCP Editors

Patients 65 years and older who receive surgery for lung cancer are living longer, claims a recent study. According to national records, lung cancer most commonly occurs in older adults, with the median age at...

...

05/12/2016

Journal of Clinical Pathways

News

Olympus Improves Specimen Sample Size for More Targeted Therapy in Lung Cancer

05/12/2016

ViziShot FLEX 19G is the largest available EBUS-TBNA needle, potentially enabling physicians to provide more targeted therapy for lung cancer patientsCENTER VALLEY, Pa., May 12, 2016 /PRNewswire/ -- Olympus, a global technology leader in...

ViziShot FLEX 19G is the largest...

05/12/2016

IO Learning

News

BTG Acquires Galil Medical, a Leader in Cryoablation

05/06/2016

London 06 May 2016Builds on BTG’s leadership in Interventional Oncology, expanding franchise into attractive and complementary ablation marketGalil Medical is a leader in cryoablation of kidney cancer with significant pipeline opportunities...

London 06 May 2016Builds on...

05/06/2016

IO Learning

Benefits of Using Comparative-Effectiveness Data in Lieu of Clinical Trials to Support Treatment Strategies

04/22/2016

JCP Editors

A lack of randomized controlled trials (RCTs) shouldn’t rule out the use of effective treatment strategies, such as stereotactic ablative radiotherapy (SABR), for lung cancer, urged a prominent oncologist recently....

A lack...

04/22/2016

Journal of Clinical Pathways

Research in Review

Novel Precision Medicine Tool Effective for Tracking Mutation-Specific Patient Outcomes

04/08/2016

JCP Editors

Researchers have developed a novel tool for calculating and displaying the survival statistics of patients with cancer depending on their genetic profile, which could help practitioners to better track...

...

04/08/2016

Journal of Clinical Pathways

Research in Review

Improving Lung Cancer Outcomes With Multidisciplinary Care

04/04/2016

JCP Editors

Multidisciplinary care (MDC) facilitates the delivery of high-quality lung cancer services, improving survival, guideline-based treatment, and quality of life for patients with the disease, according to a new...

...

04/04/2016

Journal of Clinical Pathways

Research in Review

Financial Strain Linked to More Pain and Poorer Quality of Life in Patients with Lung and Colorectal Cancers

03/06/2016

JCP Editors

Patients with cancer and limited financial means are more likely to have a higher symptom burden and decreased quality of life (QOL), according to a recent study. Rising health care costs mean that the treatments...

...

03/06/2016

Journal of Clinical Pathways

Research in Review

Positron Emission Tomography Overused in Patients With Lung and Esophageal Cancers

02/26/2016

JCP Editors

A study finding significant variation in the use of positron emission tomography (PET) scans, but no association between the number of scans and improved 2-year survival, suggests that the imaging technique might be...

A...

02/26/2016

Journal of Clinical Pathways